The global liposuction surgery devices market was estimated at around US$ 2.13 billion in 2025 and is expected to grow at a CAGR of 11.91% from 2025 to 2033, reaching approximately US$ 5.24 billion by 2033. Factors contributing to this growth are rising aesthetic procedure demand, advancement in liposuction devices, and a global trend toward body contouring and cosmetic surgery.
Liposuction surgical devices are medical equipment designed for the removal of excess fat in parts of the body. These devices are categorized by suction cannulas, which are slender tubes used to dislodge the fat cells, and suction machines, which draw the fat from the human body. Throughout the years, improved technology introduced different techniques such as tumescent liposuction, laser-assisted liposuction, and ultrasound-assisted liposuction-each varying in benefits and results.
Liposuction has become popular worldwide as the attention towards body image and appearance increases. Many desire this surgical procedure to accomplish a body type in which stubborn fatty deposits have become resistant to diet and exercise. Besides this, liposuction is also considered a shortcut to lose weight or to reshape your body, which makes it appealing to many different demographics. With improved and safer techniques, an increase in awareness of body positivity, and a greater acceptance of such procedures, more people are now considering liposuction as an option for improving their appearance. This fuels its demand globally.
Establishment: 1960
Headquarters: Canada
Bausch Health Companies Inc (Bausch Health) develops, manufactures, and markets medical devices, over-the-counter products (OTC), and pharmaceutical products. The company offers various products for therapy areas such as dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It also provides various generic and branded generic products. Bausch Health operates administrative, research and laboratory, marketing, distribution, and warehousing facilities globally. The company supplies its products either directly or indirectly in many regions globally, including the US, Canada, Africa, the Middle East, Australia, Latin America, and Europe. It also maintains manufacturing operations in the US, Brazil, Columbia, Germany, and Canada, among others.
Headquarters: Israel
InMode Ltd. is a global leader in innovative, non-invasive aesthetic medical technologies. Its foundation dates back to 2008, with headquarters in Lake Forest, Illinois. The company develops state-of-the-art technologies for the minimally invasive treatment of various skin and body conditions using radiofrequency energy. InMode's product line consists of skin rejuvenation products, body contouring, and minimally invasive surgical devices. InMode is focused on ensuring safety and efficacy in its technology. These technologies were developed in conjunction with active participation from a team comprising highly experienced professionals in dermatology and cosmetic surgery. The company is committed to improving patient experiences and outcomes while offering state-of-the-art solutions for practitioners. InMode has been able to establish itself in the aesthetic industry because of its quality innovations. This has given the company a respected name within the field.
Headquarters: United States
Genesis Biosystems, Inc. is a biotechnology company that focuses on developing new approaches for regenerative medicine and tissue engineering. The company was founded in a dream of changing patients' lives and is specialized in advanced biomaterials and cellular therapies that enhance the healing process and regenerate tissues. Their flagship products are designed to support surgical procedures, enhance recovery times, and minimize complications. With their team of experienced scientists and industry professionals, Genesis Biosystems conducts cutting-edge research while keeping practical applications in mind. The company contributes to a healthcare future through active collaborations with top-ranked academic institutions and medical professionals. The company invests in R&D and is at the top edge of innovation. Genesis Biosystems is committed to changing the regenerative medicine landscape in order to improve the quality of life of patients worldwide.
Headquarters: United States of America
Hologic Inc (Hologic) is a medical technology company that develops, manufactures, and distributes medical diagnostics, imaging systems, and surgical devices. Hologic's products comprise molecular diagnostic instrumentation, digital diagnostics systems, rapid fetal fibronectin test, oncology products, stereotactic breast biopsy systems, breast biopsy and surgery products, endometrial ablation system, fluid management system, bone densitometry, and mini-C-arm imaging system, among others. Its products are offered to clinical laboratories, hospitals, healthcare providers, and surgeons in both hospital and office settings, gynecologists, radiologists, and breast surgeons. The company distributes its products through direct sales, service personnel, and a network of independent distributors and sales representatives in North America, Europe, Asia Pacific, the Middle East, and Africa.
Headquarters: United States
Genesis Biosystems, Inc. is a US-based bio-technology company that advances regenerative medicine and tissue engineering. Committed to patient-centered solutions, Genesis researches and develops innovative biomaterials and cellular therapies for improving healing and tissue regeneration. Its key products assist surgeons with minimally invasive procedures, aiming to cut down the recovery period while reducing complications associated with these procedures. A management and scientific team composed of seasoned scientists and industry professionals at Genesis integrates sophisticated research into workable healthcare practices. The company believes in collaboration with top-ranked academic institutions and medical professional thought leaders by investing in research and development to stay ahead of the competition. Essentially, Genesis Biosystems strives to elevate the quality of patients' lives across the world with its revolutionary healthcare solutions.
The primary strength of YOLO Medical Inc. within the liposuction surgery devices market is their innovation in non-invasive and minimally invasive body contouring technologies. The company has established a strong reputation in designing laser- and light-based aesthetic systems that effectively reduce fat with minimal patient downtime. Its flagship products, including YOLO Curve and LIPLOXX, combine cutting-edge photonic technology with ease of use and are highly sought after by clinics and aesthetic professionals. The stress that YOLO places on the safety and comfort of patients, along with its clinical efficacy, enhances the company’s credibility in the field of medical aesthetics. The company’s strong R&D orientation and its responsiveness to market trends enable it to continue to introduce new solutions that align with patient demand for fat removal without surgery. It will further enhance brand trust through the global partnerships it has established for distribution and customer training. Focusing on innovation and quality, with patient satisfaction, YOLO Medical maintains the edge over others in the contemporary liposuction technologies.
The leading position of Alma Lasers Ltd. in the liposuction surgery devices market can be attributed to various factors, such as its sophisticated aesthetic technologies, strong brand presence across the world, and wide range of product offerings. Alma is highly competitive and is renowned for manufacturing laser, radiofrequency, and ultrasound-based liposuction and body contouring systems. Advanced devices such as Accent Prime and VaserLipo offer precision, safety, and superior outcomes, which benefit physicians and appeal to patients who prefer minimally invasive fat reduction procedures. Alma’s continued investment in research and clinical validation ensures the highest standards of performance and maintains credibility within the global market. The company's international distribution network and the collaboration with healthcare professionals contribute to enhancing its market access and brand loyalty. Besides, Alma's focus on integrating AI-driven and energy-based technologies makes it the pioneer in the latest innovation within aesthetic medicine. By offering clinically proven, efficient, and patient-friendly solutions, Alma Lasers maintains its dominance in the liposuction surgery devices industry.
Liposuction surgical devices are medical equipment designed for the removal of excess fat in parts of the body. These devices are categorized by suction cannulas, which are slender tubes used to dislodge the fat cells, and suction machines, which draw the fat from the human body. Throughout the years, improved technology introduced different techniques such as tumescent liposuction, laser-assisted liposuction, and ultrasound-assisted liposuction-each varying in benefits and results.
Liposuction has become popular worldwide as the attention towards body image and appearance increases. Many desire this surgical procedure to accomplish a body type in which stubborn fatty deposits have become resistant to diet and exercise. Besides this, liposuction is also considered a shortcut to lose weight or to reshape your body, which makes it appealing to many different demographics. With improved and safer techniques, an increase in awareness of body positivity, and a greater acceptance of such procedures, more people are now considering liposuction as an option for improving their appearance. This fuels its demand globally.
Top Liposuction Surgery Devices Manufacturers
SOLTA MEDICAL (Bausch Health Companies Inc)Establishment: 1960
Headquarters: Canada
Bausch Health Companies Inc (Bausch Health) develops, manufactures, and markets medical devices, over-the-counter products (OTC), and pharmaceutical products. The company offers various products for therapy areas such as dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It also provides various generic and branded generic products. Bausch Health operates administrative, research and laboratory, marketing, distribution, and warehousing facilities globally. The company supplies its products either directly or indirectly in many regions globally, including the US, Canada, Africa, the Middle East, Australia, Latin America, and Europe. It also maintains manufacturing operations in the US, Brazil, Columbia, Germany, and Canada, among others.
InMode Ltd.
Establishment: 2008Headquarters: Israel
InMode Ltd. is a global leader in innovative, non-invasive aesthetic medical technologies. Its foundation dates back to 2008, with headquarters in Lake Forest, Illinois. The company develops state-of-the-art technologies for the minimally invasive treatment of various skin and body conditions using radiofrequency energy. InMode's product line consists of skin rejuvenation products, body contouring, and minimally invasive surgical devices. InMode is focused on ensuring safety and efficacy in its technology. These technologies were developed in conjunction with active participation from a team comprising highly experienced professionals in dermatology and cosmetic surgery. The company is committed to improving patient experiences and outcomes while offering state-of-the-art solutions for practitioners. InMode has been able to establish itself in the aesthetic industry because of its quality innovations. This has given the company a respected name within the field.
Genesis Biosystems, Inc.
Establishment: 2001Headquarters: United States
Genesis Biosystems, Inc. is a biotechnology company that focuses on developing new approaches for regenerative medicine and tissue engineering. The company was founded in a dream of changing patients' lives and is specialized in advanced biomaterials and cellular therapies that enhance the healing process and regenerate tissues. Their flagship products are designed to support surgical procedures, enhance recovery times, and minimize complications. With their team of experienced scientists and industry professionals, Genesis Biosystems conducts cutting-edge research while keeping practical applications in mind. The company contributes to a healthcare future through active collaborations with top-ranked academic institutions and medical professionals. The company invests in R&D and is at the top edge of innovation. Genesis Biosystems is committed to changing the regenerative medicine landscape in order to improve the quality of life of patients worldwide.
Hologic Inc.
Establishment: 1985Headquarters: United States of America
Hologic Inc (Hologic) is a medical technology company that develops, manufactures, and distributes medical diagnostics, imaging systems, and surgical devices. Hologic's products comprise molecular diagnostic instrumentation, digital diagnostics systems, rapid fetal fibronectin test, oncology products, stereotactic breast biopsy systems, breast biopsy and surgery products, endometrial ablation system, fluid management system, bone densitometry, and mini-C-arm imaging system, among others. Its products are offered to clinical laboratories, hospitals, healthcare providers, and surgeons in both hospital and office settings, gynecologists, radiologists, and breast surgeons. The company distributes its products through direct sales, service personnel, and a network of independent distributors and sales representatives in North America, Europe, Asia Pacific, the Middle East, and Africa.
Apyx Medical
Establishment: 1982Headquarters: United States
Genesis Biosystems, Inc. is a US-based bio-technology company that advances regenerative medicine and tissue engineering. Committed to patient-centered solutions, Genesis researches and develops innovative biomaterials and cellular therapies for improving healing and tissue regeneration. Its key products assist surgeons with minimally invasive procedures, aiming to cut down the recovery period while reducing complications associated with these procedures. A management and scientific team composed of seasoned scientists and industry professionals at Genesis integrates sophisticated research into workable healthcare practices. The company believes in collaboration with top-ranked academic institutions and medical professional thought leaders by investing in research and development to stay ahead of the competition. Essentially, Genesis Biosystems strives to elevate the quality of patients' lives across the world with its revolutionary healthcare solutions.
Product Launches in the Liposuction Surgery Devices Market
Cynosure Inc.
October 2025, Cynosure Lutronic, a leading global manufacturer of laser and energy-based aesthetic medical devices, is proud to announce that the company is launching eCO2 3D, the most versatile fractional CO2 laser in aesthetics. Based on the tried-and-tested platform of the eCO2 Plus, the eCO2 3D sets the standard for resurfacing using CO2 lasers by incorporating power, precision, and control in one innovative offering.Sciton Inc.
June 2024, Sciton Inc., a pioneer in medical and aesthetic laser and light source technologies, introduces its newest innovation, BBL® HEROic™ to Canada. This latest addition in the award-winning BBL product line is the first device in aesthetics with Autodynamic Pulsing™, a fully automated pulse delivery system, transforming light-based treatments with unparalleled precision and efficiency.SWOT Analysis of the Company
YOLO Medical Inc.
Strengths: innovative non-invasive and minimally invasive body contouring technologies.The primary strength of YOLO Medical Inc. within the liposuction surgery devices market is their innovation in non-invasive and minimally invasive body contouring technologies. The company has established a strong reputation in designing laser- and light-based aesthetic systems that effectively reduce fat with minimal patient downtime. Its flagship products, including YOLO Curve and LIPLOXX, combine cutting-edge photonic technology with ease of use and are highly sought after by clinics and aesthetic professionals. The stress that YOLO places on the safety and comfort of patients, along with its clinical efficacy, enhances the company’s credibility in the field of medical aesthetics. The company’s strong R&D orientation and its responsiveness to market trends enable it to continue to introduce new solutions that align with patient demand for fat removal without surgery. It will further enhance brand trust through the global partnerships it has established for distribution and customer training. Focusing on innovation and quality, with patient satisfaction, YOLO Medical maintains the edge over others in the contemporary liposuction technologies.
Alma Lasers Ltd.
Strengths: advanced aesthetic technologies, global brand recognition, diversified product portfolioThe leading position of Alma Lasers Ltd. in the liposuction surgery devices market can be attributed to various factors, such as its sophisticated aesthetic technologies, strong brand presence across the world, and wide range of product offerings. Alma is highly competitive and is renowned for manufacturing laser, radiofrequency, and ultrasound-based liposuction and body contouring systems. Advanced devices such as Accent Prime and VaserLipo offer precision, safety, and superior outcomes, which benefit physicians and appeal to patients who prefer minimally invasive fat reduction procedures. Alma’s continued investment in research and clinical validation ensures the highest standards of performance and maintains credibility within the global market. The company's international distribution network and the collaboration with healthcare professionals contribute to enhancing its market access and brand loyalty. Besides, Alma's focus on integrating AI-driven and energy-based technologies makes it the pioneer in the latest innovation within aesthetic medicine. By offering clinically proven, efficient, and patient-friendly solutions, Alma Lasers maintains its dominance in the liposuction surgery devices industry.
Recent Development in the Liposuction Surgery Devices Market
Marina Medical
September 2024 - Marina Medical Instruments, a leading provider of superior surgical products, is pleased to announce its exclusive distribution agreement with FAGA Medical, a well-known Brazilian manufacturer of innovative medical devices. This relationship is not just about the introduction of new products but rather the filling of very critical gaps in the surgical industry with advances in technology that not only redefine standards but also provide much better alternatives to existing ones.MicroAire Surgical Instruments, LLC
Jan 2025, MicroAire Surgical Instruments, the worldwide leader in power-assisted liposuction, announced the acquisition of NEOSYAD, a medical device company and innovative developer of a revolutionary technology for the engineering of adipose tissue. This transaction further strengthens MicroAire's commitment to the advancement of medical innovation and to its leading position in the market involving adipose tissue.Sustainability Goal
Wells Johnson Co.
Wells Johnson Co., an established medical and surgical equipment manufacturer, designs its sustainability objectives according to the following themes: environmental stewardship, responsible manufacturing practices, and durable product engineering. The company intends to minimize its carbon footprint and waste generation through eco-efficient production processes and precision engineering. Wells Johnson Co. further supports product durability by making sure its surgical systems and aspiration systems endure longer to reduce replacement cycles and lessen harm to the environment. Wells Johnson Co. promotes responsible sourcing of raw materials and favors suppliers who are committed to ethical and environmentally friendly product standards. In-house, Wells Johnson Co. implements operations to maximize energy efficiency and reduce waste within its manufacturing facilities. On top of Wells Johnson Co.'s environmentally responsible goals are ethical labor practices, workplace safety, and community development. This leads to innovation with a sense of eco-friendly manufacturing and social responsibility by Wells Johnson Co., thereby establishing value creation in a sustainable future in the medical device industry and contributing to a healthy, greener future.Zeltiq Aesthetics Inc.
At Zeltiq Aesthetics Inc., the makers of CoolSculpting ®, sustainability is integral to its very mission-to help physicians advance safe and effective aesthetic innovation, responsibly. The company's sustainability objectives are threefold: to lessen environmental impact, ensure ethical production, and assure long-term patient safety. At Zeltiq, the goal is to minimize energy and waste in device manufacturing, focusing on eco-friendly material and packaging solutions. It also seeks to extend the life of its aesthetic systems through the use of responsible engineering, as well as re-manufacturing programs for its equipment. As part of AbbVie, a company committed to doing business in a responsible, sustainable manner, Zeltiq subscribes to strict ESG and compliance standards. These standards assure significant transparency into its business, as well as accountability over environmental impact. Equally paramount is social sustainability: employee welfare, proper marketing, and respect for inclusive aesthetics. By integrating sustainability principles with technology innovation, Zeltiq Aesthetics ensures that aesthetic solutions will be life-changing for patients while being responsible toward society and the environment.Market Segmentation
Liposuction Surgery Devices Market
- Historical Trends
- Forecast Analysis
Market Share Analysis - Liposuction Surgery Devices Market
SOLTA MEDICAL (Bausch Health Companies, Inc.)Overview
- Company History and Mission
- Business Model and Operations
Workforce
Key Persons
- Executive Leadership
- Operational Management
- Division Leaders
- Board Composition
Recent Development & Strategies
- Mergers & Acquisitions
- Partnerships
- Investments
Sustainability Analysis
- Renewable Energy Adoption
- Energy-Efficient Infrastructure
- Use of Sustainable Packaging Materials
- Water Usage and Conservation Strategies
- Waste Management and Circular Economy Initiatives
Product Analysis
- Product Profile
- Quality Standards
- Product Pipeline
- Product Benchmarking
Strategic Assessment: SWOT Analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
Revenue Analysis
The above information will be available for all the following companies:
- SOLTA MEDICAL (Bausch Health Companies, Inc.)
- InMode Ltd.
- Genesis Biosystems, Inc.
- Hologic Inc.
- Apyx Medical
- Cynosure Inc.
- YOLO Medical Inc.
- Sciton Inc.
- Alma Lasers Ltd.
- Wells Johnson Co.
- Invasix Ltd.
- MicroAire Surgical Instruments, LLC
- Zeltiq Aesthetics Inc.
- Erchonia Corporation
- Syneron Medical Ltd.
Table of Contents
1. Liposuction Surgery Devices Market
3. SOLTA MEDICAL (Bausch Health Companies, Inc.)
The above information will be available for all the following companies:
Companies Mentioned
- SOLTA MEDICAL (Bausch Health Companies, Inc.)
- InMode Ltd.
- Genesis Biosystems, Inc.
- Hologic Inc.
- Apyx Medical
- Cynosure Inc.
- YOLO Medical Inc.
- Sciton Inc.
- Alma Lasers Ltd.
- Wells Johnson Co.
- Invasix Ltd.
- MicroAire Surgical Instruments, LLC
- Zeltiq Aesthetics Inc.
- Erchonia Corporation
- Syneron Medical Ltd.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 2.13 Billion |
| Forecasted Market Value ( USD | $ 5.24 Billion |
| Compound Annual Growth Rate | 11.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
